Skip to main content
. 2011 Apr;77(8):2749–2754. doi: 10.1128/AEM.02481-10

Table 3.

Therapeutic effects of 3-day BCN L-1077 treatments, of various concentrations, against a mixed infection of Campylobacter jejuni and Salmonella Enteritidis 92 Rifr in 43-day-old broilersa

Chicken group (conditions) Broiler BCN dose (mg/bird) Log10 CFU/g organ homogenate (after treatment)
Lactic acid bacteria in cecal content C. jejuni
S. Enteritidis
Liver Spleen Liver Spleen
Control group (commercial feed; bacteriocin-free water) 1 0 6.79 4.86 8.65 8.60 8.60
2 6.79 4.26 8.08 8.49 8.46
3 8.57 4.80 8.56 7.90 8.28
4 8.45 7.48 8.38 7.85 8.36
5 8.11 5.26 8.46 8.52 8.59
6 8.40 7.36 8.32 8.60 8.43
Avg (no. of birds averaged) 7.85 (6) 6.96 (6) 8.45 (6) 8.41 (6) 8.46 (6)
Exptl group 1 (commercial feed; 25 mg bacteriocin L-1077/liter) 7 21.3 8.15 NDb ND ND 4.61
8 8.15 ND 4.15 4.23 ND
9 8.76 ND 3.81 ND ND
10 7.56 ND ND ND ND
11 8.60 ND ND ND ND
12 7.30 ND ND ND ND
13 8.30 ND 2.76 ND ND
14 7.28 ND 2.60 ND ND
Avg (no. of birds averaged) 8.28 (8) ND (8) ND (4), 2.69 (2), 3.81 (1), 4.15 (1) ND (7), 4.23 (1) ND (7), 4.61 (1)
Exptl group 2 (commercial feed and water with 12.5 mg BCN L-1077/liter) 15 10.9 8.46 ND ND 3.43 ND
16 7.60 ND ND ND ND
17 8.95 ND ND ND ND
18 8.81 ND 2.81 ND ND
19 8.04 ND ND ND ND
20 6.85 ND ND ND ND
21 7.77 ND ND ND 1.95
22 8.08 ND 2.34 ND ND
Avg (no. of birds averaged) 8.43 (8) ND (8) ND (6), 2.63 (2) ND (7), 3.43 (1) ND (7), 1.95 (1)
Exptl group 3 (commercial feed and water with 6.25 mg BCN L-1077/liter) 23 5.5 7.30 ND ND ND ND
24 8.11 ND ND ND ND
25 8.69 ND ND ND ND
26 6.52 ND 3.08 ND ND
27 8.60 ND 4.11 4.23 4.28
28 9.26 ND 3.34 4.46 4.43
29 8.30 ND 3.38 4.32 4.23
30 7.83 ND ND 4.32 4.15
Avg (no. of birds averaged) 8.59 (8) ND (8) ND (4), 3.28 (3), 4.11 (1) ND (4), 4.34 (4) ND (4), 4.28 (4)
a

All birds were commercially colonized with nonspecified C. jejuni.

b

ND, none detected; detection limit of >100 cells.